A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
Learn more: Motor neurone disease breakthrough: Patient trial shows impressive clinical results
The Latest on: Motor neurone disease
[google_news title=”” keyword=”motor neurone disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Motor neurone disease
- Corstorphine & Wright plan for Rob Burrow motor neurone disease centre in Leeds approvedon May 9, 2024 at 5:00 am
Corstorphine & Wright’s plans for a motor neurone disease healthcare facility in Leeds named after retired rugby league player Rob Burrow have been given the green light by the local council. Located ...
- Corstorphine & Wright’s plans for Rob Burrow motor neurone disease centre approvedon May 9, 2024 at 4:15 am
Corstorphine & Wright’s plans for a motor neurone disease healthcare facility in Leeds named after retired rugby player Rob Burrow have been given the green light by Leeds council. Located in Seacroft ...
- Nominations for first RadioTimes.com Soap Awards announcedon May 9, 2024 at 2:00 am
Nominations for the first RadioTimes.com Soap Awards 2024 have been announced. Celebrating the “very best of the much-loved British TV soaps, ‘Coronation Street’, ‘EastEnders’, ‘Emmerdale’ and ...
- Rob Burrow's podcast wins big at radio awardson May 8, 2024 at 4:34 am
Burrow's podcast Seven, made by BBC Radio Leeds, won gold awards for best new podcast and creative innovation, at the Radio Academy's Audio and Radio Industry Awards (Arias). He also won a silver in ...
- Role of Neurofilaments’ Diagnostic Value in Distinguishing MND from MMNon May 8, 2024 at 12:24 am
The following is a summary of “Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy,” published in the April 2024 issue of Neurology by Wohnrade ...
- Cork father-of-three in fight against Motor Neurone Disease: “Every day presents its challenges"on May 6, 2024 at 2:58 am
Cork man Bryan O'Brien shares his struggle with Motor Neuron Disease, as friends of the 41-year-old after he was recently diagnosed with an aggressive form of the disease ...
- Revolutionizing treatment for neurological conditions with 3D printed surgical implantson May 6, 2024 at 1:54 am
Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of diseases in the next 20 years: conditions that have baffled scientists and clinicians for ...
- Motor neurone disease ALS: Hong Kong patients inspire fundraising that helps city researchers looking for a cureon May 2, 2024 at 10:15 am
Sze has amyotrophic lateral sclerosis (ALS), a rare neurodegenerative disease that affects nerve cells in the brain and spinal cord. Falling under the umbrella of motor neurone disease (MND), ALS ...
- Motor neurone disease ALS: Hong Kong patients inspire fundraising that helps city researchers looking for a cureon May 2, 2024 at 10:15 am
A father of two lies strapped to a ventilator 24 hours a day. A Hong Kong researcher looks for a cure for ALS. Rugby fans and a woman who saw the disease kill her father are raising funds to help.
- Friends aiming to kick points at GAA grounds across Ireland in support of Roscommon woman diagnosed with Motor Neurone Diseaseon May 2, 2024 at 5:27 am
A group of five friends are setting out on a challenge to kick points in all 32 counties in support of a Roscommon woman who was recently diagnosed with Motor Neurone Disease.
via Bing News